These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20517865)

  • 1. [Neuroimaging in Alzheimer's disease: findings in plasmapheresis with albumin].
    Roca I; Cuberas-Borros G
    Rev Neurol; 2010 Mar; 50 Suppl 5():S19-22. PubMed ID: 20517865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human Albumin Grifols 5% in plasmapheresis: a new therapy involving beta-amyloid mobilisation in Alzheimer's disease].
    Boada-Rovira M
    Rev Neurol; 2010 Mar; 50 Suppl 5():S9-18. PubMed ID: 20517868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    Cuberas-Borrós G; Roca I; Boada M; Tárraga L; Hernández I; Buendia M; Rubio L; Torres G; Bittini Á; Guzmán-de-Villoria JA; Pujadas F; Torres M; Núñez L; Castell J; Páez A
    J Alzheimers Dis; 2018; 61(1):321-332. PubMed ID: 29154283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need of appropriate brain SPECT templates for SPM comparisons.
    Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic plasmapheresis and experience in Alzheimer's disease].
    Anaya F
    Rev Neurol; 2010 Mar; 50 Suppl 5():S5-8. PubMed ID: 20517867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction.
    Matsuda H; Kanetaka H; Ohnishi T; Asada T; Imabayashi E; Nakano S; Katoh A; Tanaka F
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1502-5. PubMed ID: 12397471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
    Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
    Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.
    Cuberas-Borrós G; Roca I; Castell-Conesa J; Núñez L; Boada M; López OL; Grifols C; Barceló M; Pareto D; Páez A
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4589-4600. PubMed ID: 35867135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer's disease.
    Nishimiya M; Matsuda H; Imabayashi E; Kuji I; Sato N
    Ann Nucl Med; 2008 Dec; 22(10):921-7. PubMed ID: 19142712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
    Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
    Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study.
    Boada M; Ramos-Fernández E; Guivernau B; Muñoz FJ; Costa M; Ortiz AM; Jorquera JI; Núñez L; Torres M; Páez A
    Neurologia; 2016 Sep; 31(7):473-81. PubMed ID: 25023458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
    Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT.
    Ogasawara K; Ogawa A; Ezura M; Konno H; Doi M; Kuroda K; Yoshimoto T
    J Nucl Med; 2001 Apr; 42(4):543-7. PubMed ID: 11337539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPET brain scan with (99m)Tc-ECD and CT, MRI in traumatic brain injury with chronic symptoms.
    Assadi M; Eftekhari M; Gholamrezanezhad A
    Hell J Nucl Med; 2007; 10(3):183. PubMed ID: 18084662
    [No Abstract]   [Full Text] [Related]  

  • 19. Voxel-based mapping of cortical ischemic damage using Tc 99m L,L-ethyl cysteinate dimer SPECT in acute stroke.
    Mahagne MH; David O; Darcourt J; Migneco O; Dunac A; Chatel M; Baron JC
    J Neuroimaging; 2004 Jan; 14(1):23-32. PubMed ID: 14748205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
    Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
    J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.